サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：鼓膜切開用チューブの世界市場：2023～2030年
市場調査レポート
商品コード
1374887

鼓膜切開用チューブの世界市場：2023～2030年

Global Tympanostomy Tube Market - 2023-2030

出版日
ページ情報
英文 186 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
鼓膜切開用チューブの世界市場：2023～2030年
出版日: 2023年11月01日
発行: DataM Intelligence
ページ情報: 英文 186 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

耳チューブ（鼓膜切開用チューブや鼓膜瘻チューブとも呼ばれる）は、小児耳鼻咽喉科医が手術によって鼓膜に留置する小さなチューブで、外耳炎の治療に役立ちます。

チューブの目的は、中耳に通気性を与え、液体の蓄積を防ぐことです。このチューブを使用する主な適応は、滲出液を伴う中耳炎や漿液性中耳炎につながる耳管機能障害です。これらの鼓膜切開用チューブは換気を行い、中耳の緊張を均等化し、さらなる感染症の再発を防ぎます。

市場力学：市場促進要因・市場抑制要因

小児耳感染症の高い有病率

小児耳感染症の高い有病率は、予測期間中の世界市場の成長を後押しすると予想されます。例えば、ジョンズ・ホプキンス大学によると、乳幼児の耳感染症は極めて典型的です。さらに、国立衛生研究所によると、6人に5人の子どもが3歳までに耳の感染症にかかると予想されています。米国では、毎年3000万人近くが耳の感染症で小児科を受診しています。

さらに、技術的進歩や意識の高まりなどが、予測期間中の世界市場の成長に寄与すると予想されます。

製品に関連するリスク

耳チューブを入れることは、出血、感染、継続的な排液、血液や粘液によるチューブの詰まり、鼓膜の傷や弱化、チューブの早すぎる脱落や長すぎる留置、チューブが脱落または抜去した後に鼓膜が閉じないなどの深刻な問題を引き起こすリスクがあり、予測期間中の世界市場の成長を妨げます。さらに、その他の阻害要因としては、厳しい規制機関、高い製品開発コスト、認知度の低さ、代替品の利用可能性などが挙げられます。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 小児耳感染症患者の高い有病率
    • 抑制要因
      • 製品に関連するリスク
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • 償還分析
  • 特許分析
  • 技術動向
  • 疫学分析
  • SWOT分析
  • DMI見解

第6章 COVID-19分析

第7章 材料別

  • シリコーン
  • フッ素樹脂
  • その他の材料

第8章 用途別

  • 急性中耳炎
  • 再発性滲出性中耳炎

第9章 エンドユーザー別

  • 病院
  • 専門クリニック
  • 外来手術センター（ASC）
  • その他

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他の欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他の南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他のアジア太平洋
  • 中東・アフリカ

第11章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第12章 企業プロファイル

  • EON Meditech Pvt. Ltd
    • 企業概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展
  • Atos Medical
  • Medtronic PLC, Inc.
  • Olympus Corporation
  • Preceptis Medical
  • Smith & Nephew
  • Integra LifeSciences Corporation, Inc.
  • Grace Medical
  • Koken Co., Ltd.
  • Summit Medical LLC

第13章 付録

目次
Product Code: MD7191

Overview

Ear tubes (also anointed myringotomy tubes or tympanostomy tubes) are tiny tubes that are surgically positioned in the child's eardrum by a pediatric ear, nose, and throat (ENT) surgeon to aid in treating ear infections.

The purpose of the tube is to provide ventilation to the middle ear and prevent liquid buildup. The primary indication for the usage of this tube is eustachian tube dysfunction directing to otitis media with effusion or serous otitis media. These tympanostomy tubes deliver ventilation, equalize tension in the middle ear, and avert further recurrent infections.

Market Dynamics: Drivers & Restraints

High Prevalence Pediatric Ear Infection Cases

The high prevalence of pediatric ear infections is expected to boost the global market growth during the forecast period. For instance, according to Johns Hopkins University, ear infections in infants and toddlers are extremely typical. Moreover, according to the National Institutes of Health, five in six children are expected to encounter an ear infection before the age of 3. Over 80% of children have at least one ear infection by the time they are 3 years old. In the U.S., ear infections make up for almost 30 million visits to the pediatrician each year the most common reason children visit their doctor.

Furthermore, growing technological advancements and growing awareness among others are expected to contribute to the global market growth during the forecast period.

Product Associated Risks

Putting in an ear tube carries a risk of serious problems including bleeding, infection, ongoing fluid drainage, blocked tubes from blood or mucus, eardrum scarring or weakening, tubes falling out too soon or staying in too long and the eardrum not closing after the tube falls out or is taken out, hampering the global market growth during the forecast period. Moreover, other restraining factors include stringent regulatory bodies, high product development costs, low awareness and avalibility of substituents among others.

Segment Analysis

The global tympanostomy tube market is segmented based on material, application, end user and region.

Acute Otitis Media (AOM) is Expected to Dominate Market

Acute otitis media (AOM) is described as an infection of the middle ear and is the second most typical pediatric infection diagnosis in the emergency division following upper respiratory infections. Although acute otitis media can transpire at any age, it is highly typical to be detected between the ages of 6 to 24 months. The high prevalence of acute otitis media is expected to boost segment growth during the forecast period.

For instance, according to NIH, roughly 80% of all children are estimated to experience a case of otitis media in their lifetime, and between 80% to 90% of all children are expected to have otitis media with an effusion before school age. Moreover, according to the American Academy for Pediatrics, more than 5,000,000 AOM cases surface annually in US children.

Geographical Analysis

North America is Expected to Dominate the Global Market

Owing to the high prevalence and increasing adoption of Tympanostomy Tube treatment in North America the region is estimated to dominate the global market throughout the forecast period. For instance, in 2021, an NIH investigation documented that ear infections were among the most typical infections in United States children yearly.

Moreover, according to the National Institute on Deafness and Other Communication Disorders in March 2021, 5 out of 6 children in the United States experience ear infection by the time they are three years old. Further, in August 2022, Phoenix Children's Hospital executed an ear tube replacement surgery utilizing the Hummingbird tympanostomy tubes on a patient under two years old with a constant ear infection in the United States.

COVID-19 Impact Analysis

It is confirmed that the COVID-19 pandemic has directed to significant transformations in healthcare delivery, with telehealth evolving more widely embraced to minimize transmission. New policies were also issued, which outlined new protocols for evaluating and managing common pediatric ear, nose, and throat infections.

These modifications have in some cases postponed or substituted surgical interventions. Further, ongoing investigation has directed to new understandings into the pathophysiology of specific pediatric diseases, including otitis media, which suggests that upper respiratory infection exposure may play a larger role than previously thought.

Market Segmentation

By Material

  • Silicone
  • Fluoroplastic
  • Other Materials

By Application

  • Acute Otitis Media
  • Recurrent Otitis Media with Effusion

By End User

  • Hospital
  • Specialty Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In August 2022, Perceptis Medical Inc. obtained United States FDA authorization for the Hummingbird Tympanostomy tube system for extended indications for usage in office pediatric ear tube procedures.
  • In February 2022, Medtronic introduced the NuVenet Eustachian tube dilation balloon, it is employed in the treatment of the eustachian tube from pathogens, equalizing air pressure on either side of the eardrum and aiding drain secretion from the middle ear cleft.

Competitive Landscape

The major global players in the market include: EON Meditech Pvt. Ltd, Atos Medical, Medtronic PLC, Olympus Corporation, Preceptis Medical, Smith & Nephew, Integra Lifesciences Corporation, Grace Medical, Summit Medical LLC and Koken Co., Ltd. Among others.

Why Purchase the Report?

  • To visualize the global tympanostomy tube market segmentation based on material, application, end user and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of tympanostomy tube market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global tympanostomy Tube market report would provide approximately 61 tables, 57 figures and 186 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Material
  • 3.2. Snippet by Application
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. High Prevalence Pediatric Ear Infection Cases
    • 4.1.2. Restraints
      • 4.1.2.1. Product Associated Risks
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Reimbursement Analysis
  • 5.6. Patent Analysis
  • 5.7. Technology Trend
  • 5.8. Epidemiology
  • 5.9. SWOT Analysis
  • 5.10. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Material

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 7.1.2. Market Attractiveness Index, By Material
  • 7.2. Silicone*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Fluoroplastic
  • 7.4. Other Materials

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Acute Otitis Media*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Recurrent Otitis Media with Effusion

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospital*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Specialty Clinics
  • 9.4. Ambulatory Surgical Centers (ASCs)
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. EON Meditech Pvt. Ltd*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Atos Medical
  • 12.3. Medtronic PLC, Inc.
  • 12.4. Olympus Corporation
  • 12.5. Preceptis Medical
  • 12.6. Smith & Nephew
  • 12.7. Integra LifeSciences Corporation, Inc.
  • 12.8. Grace Medical
  • 12.9. Koken Co., Ltd.
  • 12.10. Summit Medical LLC

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us